BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2514651)

  • 1. [Comparative study of 2 dosages of a new antihypertensive agent, cicletanine, in elderly subjects].
    Jungers P; Gavardin T; Salom M; Tarrade T; Berthet P
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():125-9. PubMed ID: 2514651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of three studies to determine the efficacy and tolerance of cicletanine in the short- and long-term treatment of essential hypertension.
    Fodor GP; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):195-204. PubMed ID: 3046883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerance of cicletanine, a new antihypertensive agent: overview of 1226 treated patients.
    Tarrade T; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):205-14. PubMed ID: 3046884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the optimal dose of the antihypertensive drug cicletanine hydrochloride in man.
    Guinot P; Jewitt-Harris J; Tarrade T
    Arzneimittelforschung; 1989 Jan; 39(1):86-9. PubMed ID: 2655611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antihypertensive effectiveness and tolerance of cicletanine. Results obtained with monotherapy in a large population].
    Tarrade T; Berthet P; Paillasseur JL; Bosquet D; Allard M
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():91-7. PubMed ID: 2514675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and tolerability of cycletanine in aged patients with hypertension].
    Bodak A; Gavardin T; Salom M; Tarrade T; Forette F; Jungers P; Metellus J
    Therapie; 1989; 44(2):101-6. PubMed ID: 2756515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the effectiveness and tolerance of cicletanine in patients with essential hypertension treated with beta-blockers].
    Clerson P; Deltour L; Billaut P; Tarrade T; Berthet P; Pauchant M
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():113-8. PubMed ID: 2575369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the effectiveness of a cicletanine-enalapril combination in hypertensive patients].
    Safar M; Cournot P; Duchier J
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():119-24. PubMed ID: 2558622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of cicletanine efficiency and tolerance in hypertensive patients treated with beta-blockaders].
    Clerson P; Deltour L; Billaut P; Tarrade T; Berthet P; Pauchant M
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1293-7. PubMed ID: 2573325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perindopril: first-line treatment for hypertension.
    Zanchetti A; Desche P
    Clin Exp Hypertens A; 1989; 11 Suppl 2():555-73. PubMed ID: 2691129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
    Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dose-effectiveness relationship of cicletanine at short-term in moderately to severely hypertensive patients].
    Fritel D
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():99-102. PubMed ID: 2514676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up.
    Eveson DJ; Robinson TG; Potter JF
    Am J Hypertens; 2007 Mar; 20(3):270-7. PubMed ID: 17324738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.